{"name":"Partners in Health","slug":"partners-in-health","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"sofosbubir/velpatasvir","genericName":"sofosbubir/velpatasvir","slug":"sofosbubir-velpatasvir","indication":"Chronic hepatitis C virus (HCV) infection, all genotypes, with or without cirrhosis","status":"marketed"},{"name":"sofosbubir/velpatasvir/voxilaprevir","genericName":"sofosbubir/velpatasvir/voxilaprevir","slug":"sofosbubir-velpatasvir-voxilaprevir","indication":"Chronic hepatitis C virus infection (genotypes 1-6), including treatment-experienced patients with compensated cirrhosis","status":"marketed"}]}],"pipeline":[{"name":"sofosbubir/velpatasvir","genericName":"sofosbubir/velpatasvir","slug":"sofosbubir-velpatasvir","phase":"marketed","mechanism":"Sofosbuvir inhibits hepatitis C virus NS5B polymerase while velpatasvir inhibits NS5A protein, together blocking viral replication.","indications":["Chronic hepatitis C virus (HCV) infection, all genotypes, with or without cirrhosis"],"catalyst":""},{"name":"sofosbubir/velpatasvir/voxilaprevir","genericName":"sofosbubir/velpatasvir/voxilaprevir","slug":"sofosbubir-velpatasvir-voxilaprevir","phase":"marketed","mechanism":"This combination inhibits three different hepatitis C virus enzymes (NS5B polymerase, NS5A protein, and NS3/4A protease) to block viral replication.","indications":["Chronic hepatitis C virus infection (genotypes 1-6), including treatment-experienced patients with compensated cirrhosis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOdjdIc3MyWXhORW0yUXR5aktlblktcTJKYk00S29XMFYtMDZTck9hLU1ZU2NQMFFsX2l6NGF2dmJ6NlY4ZnNRRFZTclhhVWFqTHhISi1ySEw0WDBhQ3RDTVliOTctb0xDcTVRMFRhazN6NE9KX050VEd1VjFNZUo0YlNQd0ZRd3BIMDY2OGs3ZVdFLTJONzVaNHo1VkhPV0xnMXF0dFVncFBMVUpkTXc?oc=5","date":"2026-03-11","type":"pipeline","source":"Devex","summary":"Rethinking how pharma succeeds in low- and middle-income countries - Devex","headline":"Rethinking how pharma succeeds in low- and middle-income countries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNazh2WTVKU1lfWmVSNjRONVFmTUh1TDZycU5CSGU0Q3ZCSW4yM0VONjktemk2QlRhdFFPaUFFdW5zQjZXWmxNaFcySlFTc05DRFVQcjg2b1pyYk1EbG92cDZWTXNkalJENGZ1bnRGTl9jUDBJMFVXa2hrbllyTkoxQ05HUEswZUtXNk16TmhvNWJvdG1RWXVINQ?oc=5","date":"2026-01-09","type":"pipeline","source":"pwc.com","summary":"Future of Pharma: Breakthroughs at Scale - pwc.com","headline":"Future of Pharma: Breakthroughs at Scale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQLW5BRzlxbm9MN3ctTzNfd1Y0SEg0NmtYUkFvLW80X05kRTlMZTZOVjNKaTJJVDg3U3Vva0M5M3R5bXo5SlEtSnE5d0ZkVXVLRGpOVHRtN0NuSE5Uekoyb2Z1c0VubGFmbHZyWEd3UThrM01saC1SY1NOWHQtTHpvb3M5QXdfak9ZcEU0dlkzdE1tUGhxRnFXZ0dVZzJNSVhRYS14RXRWamg1el9ZYUFNSUg2RQ?oc=5","date":"2026-01-07","type":"pipeline","source":"BioSpace","summary":"LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference - BioSpace","headline":"LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOWTdrZGNyN2dfc2wxQ29BWU96WFRXaTVOS2pYUDA0aGExckVnWHQ1TUhpamFYMFdTYWJ4aHBPU3NORGkteEJ2dC1tSWxtN1cyaXdjSVZxRjZvM3ZWenVCTWxTbTJCV1F4eUhyZXMzbGFmOFJuR1AydHRFX2RaVV9wTERKbkhkWUd4Q2lZOUdB?oc=5","date":"2025-07-30","type":"deal","source":"WSJ","summary":"Exclusive | KKR Pushes Further Into Healthcare With Deal for Pharma Royalty Business - WSJ","headline":"Exclusive | KKR Pushes Further Into Healthcare With Deal for Pharma Royalty Business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOVU1HX2c5UnlNT1d0ZWY3TlAzVlFFbWZKSTRsb1RCMUJYN1hMaXp2c1pPUS1VZFFtd2hFa3BzNnp5b0gtdnhxcVVtYjE4aTlwa3Y5bngxSFFyTGZIRW81U2ZEWUNfWXQ5aGlZNndrRktla1BRRDFwTDVyaENZSG5SZ2d2cDdybVVyRDFlRWx4YVhXS2h1cDZn?oc=5","date":"2025-06-09","type":"deal","source":"Pharmaceutical Commerce","summary":"Bridging the Gap Between Strategy and Practice in IDN Partnerships - Pharmaceutical Commerce","headline":"Bridging the Gap Between Strategy and Practice in IDN Partnerships","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQclVfZGpJWlNiaUY2dFBiY3hrSF9TaHpGeXJpS3VIMEZvbzlmYVdVbVJnU3FuZTRRSS1fTHBrV1RXYjd6a0pYeDFrZlFfdzAtN2JBdl9WWmJSdWZlRGNUVy03VFVySDNzaXlFZGZxdzRJbHpqSl9QVkpfR2NmWDdYRFgwVXVncjdXTVB2eHh1T1VVOGUweXAwYTZiYldqY2V3Nmkwc2oxOUo?oc=5","date":"2025-06-02","type":"pipeline","source":"Fierce Pharma","summary":"Essence Patient Solutions CEO on transforming pharma's role in healthcare - Fierce Pharma","headline":"Essence Patient Solutions CEO on transforming pharma's role in healthcare","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFBZWVNVT2ZoYldhNmdWazNZNnc3UUFYQzJOSWZIYkVWMkV1SjBYTGFQc0NQaDdtYjBKbjI1Mm5VSlBWdTNMaUtyUi1Xbk00SHRzalh0empOX3djSGRjOEN5aXhPcGk1STRBOUd6QTNJV2x3NDR3T1E?oc=5","date":"2025-04-29","type":"pipeline","source":"GrowthCap","summary":"The Top Healthcare Investors of 2025 - GrowthCap","headline":"The Top Healthcare Investors of 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9lNHhZU0xCeVRKTjNhd29wMkVtVWpCbHQ3ZTlWWnpRWFRIWlZRcVlWLTBBUm5fV3dncy1sbE4zaWFiSGdiWTUxcHo1eHdKQXNiWG13YjN4V1ZfY0hLV1ZTa1Z6UGVqN0NMbEE?oc=5","date":"2025-04-15","type":"deal","source":"Bessemer Venture Partners","summary":"The Healthcare AI Adoption Index - Bessemer Venture Partners","headline":"The Healthcare AI Adoption Index","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxNdVVJT2ZReUVWYUwxbmpYcEh6OWdXeHFtbW9tZGUwUGVPSllTcHVFdElFR05KNHNadS1GNDFidUZCbENoRW44ZGU5SFFjdU9GZEJtU2VUcXlMYUNTMWJ2VGJWeGRtVzVQTEYwSWtPU1dFdzFpSnBGUkh2Y2JzRWw3c3FNcXY5Mi0xWnFJWGd6TU1PcUlZcThoT1l0NzE0VUFZZmR4S1gzcTFXNXlJYnBlclhpLUJORkkxbUl4aV93SEZTNi1ITUF5NDBrTDhOU0RoR2N1NERLN2IxbGU3UjBqQWtqVTZZLU5EcnNHeXFiVnJKeTVZQVV0YmQ3YV9NdXVZZEFHVW1Ncy1zSktSd0o4?oc=5","date":"2025-04-10","type":"deal","source":"prnewswire.com","summary":"Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain - prnewswire.com","headline":"Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves o","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5zVGx5VU9melpRZUJkc21IRVJMUjRPbkIxZ1ozTWdRMWczZ2hLcmR6eFl3bjNMaHdlM0ZybWY2NmlHXzNHNjU3QWc4MUxfS2tnWHNkZlo1SmZGd2hoNXJr?oc=5","date":"2025-02-27","type":"deal","source":"Nature","summary":"A scoping review of ethical aspects of public-private partnerships in digital health | npj Digital Medicine - Nature","headline":"A scoping review of ethical aspects of public-private partnerships in digital health | npj Digital Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOUl8ySHltVGR2WkVDZzY0YklMLVFZdXhrYVZuX19FRFRnSzdPU29GQ2dfYXRobWIzbW9oSDFxOXRjVWQyVWNvNzRBRy1DWnI1eVhFQ056ME1pSjVEeEZfSnlrdnhNSWdHX01DSU5hWUh1SkJWSnctMU1PMnNwLXhfdEQ3ck9qaHlwVG5meldGNk45VjBVS2J5UHV3?oc=5","date":"2024-07-09","type":"deal","source":"Yahoo Finance","summary":"Essential Pharma launches campaign with International Health Partners to donate life-saving medicines to disaster-hit countries - Yahoo Finance","headline":"Essential Pharma launches campaign with International Health Partners to donate life-saving medicines to disaster-hit co","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBzWGpSX182akVUWjBBSlJfOVdDX0JkV0xxbVg5cUJ1aWExTG1BeEs5aHFiLTRBY1VPa1drbURrRjJkT1BBR3ppaWpWUWc1SWwtemFORWduZ3dxSm83N0RjNXNRZ1Y1STNEQjZ0ckx2ak5pYnYzS2lmZ1VqTXU?oc=5","date":"2023-05-02","type":"deal","source":"Andreessen Horowitz","summary":"Channel Partnerships in Healthcare - Andreessen Horowitz","headline":"Channel Partnerships in Healthcare","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}